Literature DB >> 18425211

Synthesis, Solution and Solid State Structure of Titanium-Maltol Complex.

José L Lamboy1, Antonio Pasquale, Arnold L Rheingold, Enrique Meléndez.   

Abstract

The reaction of Cp(2)TiCl(2) with two equivalents of maltol (3-hydroxy-2-methyl-4-pyrone) in water, at room temperature and pH of 5.4, leads to a complete replacement of Cp and chloride ligands affording, Ti(maltolato)(2)(OH)(2.) The complex has been characterized by IR, NMR and ESI-MS spectroscopic and cyclic voltammetry methods. In DMSO-d(6) solution, the complex shows two isomers in a ratio of 4:1, in which one OH signal can be identified per isomer. This suggests that in solution the complex is monomeric, most likely a chiral cis-Ti(maltolato)(2)(OH)(2) and trans-Ti(maltolato)(2)(OH)(2). The monomeric nature of the complex (in water/methanol 1:1) was verified by ESI-MS spectroscopy, showing a parent peak at 329 m/z. Electrochemical behavior of Ti(maltolato)(2)(OH)(2) using cyclic voltammetry experiments showed the complex undergoes irreversible reduction in aprotic solvents. In D(2)O solution, at pH of 8.4, the (1)H NMR spectrum of the complex shows a mixture of monomer and tetramer Ti(IV)-maltol complexes in a ratio of 1:1. The crystallization of Ti(maltolato)(2)(OH)(2) at pH of 8.4 leads to the formation of [Ti(4)(maltolato)(8)(μ-O(4))]•18H(2)O. A single crystal of [Ti(4)(maltolato)(8)(μ-O(4))]•18H(2)O was analyzed by X-ray diffraction methods. The complex crystallizes in a monoclinic space group P2(1)/c with a = 12.617(4) Å, b = 24.058(8) Å, c = 22.686(7) Å, β= 97.678(4)° and V = 6824(4) Å(3) for Z = 4. Solid state structure determination of the Ti-maltol complex showed to be tetrameric, containing two bridging oxides (in cis position) and two bidentate maltol ligands per titanium in a pseudo-octahedral coordination geometry.

Entities:  

Year:  2007        PMID: 18425211      PMCID: PMC1948875          DOI: 10.1016/j.ica.2006.10.042

Source DB:  PubMed          Journal:  Inorganica Chim Acta        ISSN: 0020-1693            Impact factor:   2.545


  11 in total

1.  Non-platinum chemotherapeutic metallopharmaceuticals.

Authors:  M J Clarke; F Zhu; D R Frasca
Journal:  Chem Rev       Date:  1999-09-08       Impact factor: 60.622

2.  Titanocene dichloride--the first metallocene with cancerostatic activity.

Authors:  H Köpf; P Köpf-Maier
Journal:  Angew Chem Int Ed Engl       Date:  1979-06       Impact factor: 15.336

3.  Synthesis, structures, and catalytic reactions of ring-substituted titanium(IV) complexes.

Authors:  Yanlong Qian; Jiling Huang; Muhammad D Bala; Bing Lian; Hao Zhang; Hao Zhang
Journal:  Chem Rev       Date:  2003-07       Impact factor: 60.622

4.  The formation of maltol by the degradation of streptomycin.

Authors:  J R SCHENCK; M A SPIELMAN
Journal:  J Am Chem Soc       Date:  1945-12       Impact factor: 15.419

5.  Coordination chemistry and insulin-enhancing behavior of vanadium complexes with maltol C6H6O3 structural isomers.

Authors:  Katayoun Saatchi; Katherine H Thompson; Brian O Patrick; Maren Pink; Violet G Yuen; John H McNeill; Chris Orvig
Journal:  Inorg Chem       Date:  2005-04-18       Impact factor: 5.165

6.  Syntheses, structure, and reactivity of chiral titanium compounds: procatalysts for olefin polymerization.

Authors:  P Sobota; K Przybylak; J Utko; L B Jerzykiewicz; A J Pombeiro; M F Guedes da Silva; K Szczegot
Journal:  Chemistry       Date:  2001-03-02       Impact factor: 5.236

7.  Preparation and characterization of vanadyl complexes with bidentate maltol-type ligands; in vivo comparisons of anti-diabetic therapeutic potential.

Authors:  Katherine H Thompson; Barry D Liboiron; Yan Sun; Karycia D D Bellman; Ika A Setyawati; Brian O Patrick; Veranja Karunaratne; Gulnar Rawji; Jeffrey Wheeler; Kymberley Sutton; Sanjay Bhanot; Carrie Cassidy; John H McNeill; Violet G Yuen; Chris Orvig
Journal:  J Biol Inorg Chem       Date:  2002-09-12       Impact factor: 3.358

8.  Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane.

Authors:  T Schilling; K B Keppler; M E Heim; G Niebch; H Dietzfelbinger; J Rastetter; A R Hanauske
Journal:  Invest New Drugs       Date:  1996       Impact factor: 3.850

9.  Comparison of anti-hyperglycemic effect amongst vanadium, molybdenum and other metal maltol complexes.

Authors:  Katherine H Thompson; Jessica Chiles; Violet G Yuen; Jeremy Tse; John H McNeill; Chris Orvig
Journal:  J Inorg Biochem       Date:  2004-05       Impact factor: 4.155

Review 10.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

View more
  3 in total

1.  Titanium(IV) complexes: cytotoxicity and cellular uptake of titanium(IV) complexes on caco-2 cell line.

Authors:  Ramón Hernández; Janet Méndez; José Lamboy; Madeline Torres; Féliz R Román; Enrique Meléndez
Journal:  Toxicol In Vitro       Date:  2009-09-20       Impact factor: 3.500

2.  Structure-activity studies of Ti(IV) complexes: aqueous stability and cytotoxic properties in colon cancer HT-29 cells.

Authors:  Ramón Hernández; José Lamboy; Li Ming Gao; Jaime Matta; Félix R Román; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2008-02-21       Impact factor: 3.358

3.  Synthesis, Ti(IV) intake by apotransferrin and cytotoxic properties of functionalized titanocene dichlorides.

Authors:  Li Ming Gao; Ramón Hernández; Jaime Matta; Enrique Meléndez
Journal:  J Biol Inorg Chem       Date:  2007-06-14       Impact factor: 3.358

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.